Skip to main content
Caplight Logo









Cmbio

Cmbio

Private
CopenhagenHealthcare & Life Scienceshttps://cmbio.io/

Last Round

VC Round

Oct 11, 2022

Total Funding Raised

$10M

Company Overview

Cmbio is a biotechnology company that provides a global multi-omics science and technology platform for microbiome and metabolomics research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Subscription SaaS, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

multi-omics servicescontract research organizationCROmicrobiome servicesomics CROshotgun metagenomicsmetabolomicsbioinformatics servicesproteomicslong-read metagenomicssequencing as a serviceD2C testing enablementGxP compliantCLIA certifieddrug discovery servicesclinical trial supportagricultural microbiomedigital biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cmbio Comparables

Compare Cmbio with similar companies based on industry and business-model similarity.

Cmbio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BaseClear B.V.
78%
Mapmygenome
77%
Metabolon
74%

Cmbio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 11, 2022
Series BJan 27, 2016
Series ADec 15, 2011

Key People

Founding team and executive leadership

Anders Grøn

Chief Executive Officer

Executive Team

Mads Toft Søndergaard

Chief Technology Officer

Executive Team

Cmbio Investors

Notable investors and investment history

Cmbio investors
InvestorRounds
Applied Value GroupSeries B
Seventure PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    Grew 18% QoQ, from 94 to 111 employees.

  • Apr 6, 2025

    Grew 83% QoQ, from 54 to 99 employees.

Cmbio Filings

Explore SEC and related filing metadata, where available.

Cmbio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cmbio's valuation, stock price, and market status.

Is Cmbio a public or private company?

Cmbio is a private company.

What is the current stock price of Cmbio?

Cmbio is a private company with no public stock price. No recent secondary market data is available.

How much is Cmbio worth (valuation)?

Valuation information for Cmbio is not publicly available.

Can I buy Cmbio stock?

Cmbio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cmbio's last funding round?

Cmbio's most recent funding round was VC Round on October 11, 2022.

Who are the main investors in Cmbio?

Key investors in Cmbio include Applied Value Group, Seventure Partners.

Will Cmbio IPO soon?

No public IPO plans have been announced for Cmbio.

How can I track Cmbio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cmbio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range86
Year Founded2015
Last FundingOct 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?